Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands |
12 Months Ended |
Dec. 31, 2021 |
Dec. 31, 2020 |
| Revenue: |
|
|
| Revenue |
$ 2,818
|
$ 5,416
|
| Operating costs and expenses: |
|
|
| Cost of goods sold |
3,753
|
6,032
|
| Research and development |
4,095
|
4,017
|
| Selling, general and administrative |
30,935
|
36,330
|
| Total operating costs and expenses |
38,783
|
46,379
|
| Loss from operations |
(35,965)
|
(40,963)
|
| Other income: |
|
|
| Interest expense |
(2,291)
|
(3,305)
|
| Interest income and other income, net |
124
|
583
|
| Non-cash interest income on liability related to sale of future royalties |
3,038
|
3,310
|
| Total other income |
871
|
588
|
| Net loss before income taxes |
(35,094)
|
(40,375)
|
| Provision for income taxes |
5
|
4
|
| Net loss |
(35,099)
|
(40,379)
|
| Comprehensive loss |
$ (35,099)
|
$ (40,379)
|
| Net loss per share of common stock, basic and diluted (in dollars per share) |
$ (0.29)
|
$ (0.47)
|
| Shares used in computing net loss per share of common stock, basic and diluted –see Note 15 (in shares) |
119,860,266
|
85,257,008
|
| Product [Member] |
|
|
| Revenue: |
|
|
| Revenue |
$ 1,005
|
$ 2,521
|
| Contract and Other Collaboration [Member] |
|
|
| Revenue: |
|
|
| Revenue |
$ 1,813
|
$ 2,895
|